1. Home
  2. UVE vs CSTL Comparison

UVE vs CSTL Comparison

Compare UVE & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UVE
  • CSTL
  • Stock Information
  • Founded
  • UVE 1990
  • CSTL 2007
  • Country
  • UVE United States
  • CSTL United States
  • Employees
  • UVE N/A
  • CSTL N/A
  • Industry
  • UVE Property-Casualty Insurers
  • CSTL Medical Specialities
  • Sector
  • UVE Finance
  • CSTL Health Care
  • Exchange
  • UVE Nasdaq
  • CSTL Nasdaq
  • Market Cap
  • UVE 666.1M
  • CSTL 661.7M
  • IPO Year
  • UVE 1992
  • CSTL 2019
  • Fundamental
  • Price
  • UVE $28.86
  • CSTL $24.23
  • Analyst Decision
  • UVE
  • CSTL Strong Buy
  • Analyst Count
  • UVE 0
  • CSTL 6
  • Target Price
  • UVE N/A
  • CSTL $37.67
  • AVG Volume (30 Days)
  • UVE 190.8K
  • CSTL 263.6K
  • Earning Date
  • UVE 10-23-2025
  • CSTL 11-03-2025
  • Dividend Yield
  • UVE 2.69%
  • CSTL N/A
  • EPS Growth
  • UVE N/A
  • CSTL N/A
  • EPS
  • UVE 2.28
  • CSTL N/A
  • Revenue
  • UVE $1,567,371,000.00
  • CSTL $346,269,000.00
  • Revenue This Year
  • UVE $1.87
  • CSTL N/A
  • Revenue Next Year
  • UVE N/A
  • CSTL N/A
  • P/E Ratio
  • UVE $12.54
  • CSTL N/A
  • Revenue Growth
  • UVE 5.64
  • CSTL 20.40
  • 52 Week Low
  • UVE $18.72
  • CSTL $14.59
  • 52 Week High
  • UVE $30.48
  • CSTL $35.84
  • Technical
  • Relative Strength Index (RSI)
  • UVE 61.05
  • CSTL 62.16
  • Support Level
  • UVE $27.89
  • CSTL $22.10
  • Resistance Level
  • UVE $30.02
  • CSTL $23.19
  • Average True Range (ATR)
  • UVE 0.80
  • CSTL 0.86
  • MACD
  • UVE -0.15
  • CSTL 0.08
  • Stochastic Oscillator
  • UVE 47.59
  • CSTL 95.74

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: